Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.
about
An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imagingReengineering chimeric antigen receptor T cells for targeted therapy of autoimmune diseaseDual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.Murine models of acute leukemia: important tools in current pediatric leukemia research.A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines.In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyBioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emissionAnti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.Pre-clinical evaluation of tyrosine kinase inhibitors for treatment of acute leukemia.Pharmacogenomic considerations of xenograft mouse models of acute leukemia.T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma.Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyY-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.Accounting for filter bandwidth improves the quantitative accuracy of bioluminescence tomography.Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastoma.Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia.Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL.Ultrasound-mediation of self-illuminating reporters improves imaging resolution in optically scattering media.
P2860
Q27311229-B92FB226-87CB-4C51-B6D7-E5FFA39E8A4FQ28276800-1A1AD2ED-F0A8-43DE-BFB5-356239C9F50CQ30827633-9E635CB5-4637-45B1-9995-410751EF0E2EQ33606018-7AA320CB-5282-497C-95EA-DCA2126362B2Q33692070-2F607491-0219-496B-8ED2-1C3B96F6D44FQ34541243-3EB5AAC5-9CBB-4FC2-863D-006669F71E4EQ36349583-CF64D4B5-2DEE-41CF-80DC-C51628998084Q36578558-9B7096DE-9C52-4C8C-80DA-D55D332C1A78Q36619703-8FCB6983-7FCA-4F17-9A2E-D562AEDDB037Q37582854-6E6BC984-3B58-43A0-9E0D-F292CEFE672AQ38061500-8E3AA693-DC27-485D-A033-85217F17C9E2Q38564461-10CD723F-5B7B-466F-A7B1-97C07C6EBC40Q38777377-F85175A0-A0F0-4BA0-910F-9057FB2A8F34Q38998632-2E399D82-1E4E-47EB-A861-3E0049B44F3CQ40588429-23907F1B-59C6-46A8-9D5D-32FCAC186AECQ41613624-085A9934-4C7F-4B5F-B577-D85EEBCD2E11Q42559059-85317A63-88F3-4280-98F2-4786A85A7D8FQ49959951-2066F307-2735-447A-990B-830EB924E0F2Q50033967-A8B3AECA-D215-4D88-8659-2C145F882701Q50209854-80F1349D-75D0-4577-910B-1E96F0B4F995Q53072705-510CB7C4-4703-4630-9988-F1394211AC12
P2860
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@ast
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@en
type
label
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@ast
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@en
prefLabel
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@ast
Noninvasive bioluminescent ima ...... tegy for preclinical modeling.
@en
P2093
P2860
P50
P921
P1433
P1476
Noninvasive bioluminescent ima ...... ategy for preclinical modeling
@en
P2093
Carl H June
Carmine Carpenito
David M Barrett
Jonathan D Fish
Stephan A Grupp
P2860
P304
P356
10.1182/BLOOD-2011-04-346528
P407
P577
2011-08-19T00:00:00Z